Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived−100.0% vs Q4 2017 Net Income-$494.48K-$494.48KderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$432,515N/M Operating Cash Flowderived-$65,642N/M Free Cash Flowderived-$65,642N/M ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end